Erudio Healtherudio.com
Drug
trastuzumab emtansine
1 HCP commentary report on clinical trials studying trastuzumab emtansine. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| IMpassion050 NCT03726879 · Hoffmann-La Roche | HER2-positive early breast cancer | Phase 3 | 175 | 16 | Standard | Oct 31, 2026 | Preview |